Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-155.81	-180.44	-70.54
Graham Fair Price	-22.01	3.04	3.90
PEG	556.33	0.80	-0.12
Price/Book	39.77	5.00	3.58
Price/Cash Flow	14.15	-120.71	-140.60
Prices/Earnings	-121.72	-30.51	-13.76
Price/Sales	231.78	311.50	93.89
Price/FCF	14.15	-120.71	-140.60
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	8.48	0.31	0.29
Operating Margin	-71.10	-2.77	-1.62
ROA	39.02	-0.03	-0.05
ROE	-0.07	-0.04	36.96
ROIC	-0.06	-0.04	38.69
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.38	0.23	68.68
Dividends QOQ	-0.11	0.41	281.85
EBIT QOQ	-1.05	0.31	-70.39
EPS QOQ	-1.13	0.38	-66.22
FCF QOQ	0.44	-0.56	25.59
Revenue QOQ	0.38	-0.60	55.98
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	863.37	2215.92	156.66
Days Sales Outstanding (DSO)	1016.51	2437.76	139.82
Inventory Turnover	0.10	0.04	-61.04
Debt/Capitalization	0.11	0.15	37.81
Quick Ratio	3.57	3.41	-4.61
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3.22	3.16	-1.77
Cash	0.45	0.45	-0.63
Capex	-0.04	-0.05	-7.86
Free Cash Flow	-0.08	-0.13	-59.92
Revenue	0.12	0.05	-58.62
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	5.33	5.15	-3.44
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.40	-1.11	178.57
Naive Interpretation	Member

06 - Financial Health · Bad

Rating